首页> 外文期刊>Journal of Atrial Fibrillation >Idiopathic ventricular tachycardia: transcatheter ablation or antiarrhythmic drugs?
【24h】

Idiopathic ventricular tachycardia: transcatheter ablation or antiarrhythmic drugs?

机译:特发性室性心动过速:经导管消融或抗心律不齐药物?

获取原文
           

摘要

Introduction Ventricular tachycardia or frequent premature ventricular contractions (PVCs) can occur in the absence of any detectable structural heart disease. In this clinical setting, these arrhythmias are termed idiopathic. Usually, they carry a benign prognosis and any potential ablative intervention is carried out if patients are highly symptomatic or, more importantly, if frequent ventricular arrhythmias can lead to ventricular dysfunction. Methods In this paper, different forms of idiopathic ventricular tachycardia are reviewed. Outflow tract ventricular tachycardia from the right ventricle is the most frequent form of the so-called idiopathic ventricular tachycardia. Other forms of idiopathic ventricular arrhythmias include ventricular tachycardia/PVCs arising from tricuspid annulus, from the mitral annulus, inter-fascicular ventricular tachycardia and papillary muscle ventricular tachycardia. When interventional treatment is deemed necessary, detailed mapping ( earliest activation during VT/PVC, pace mapping ) is crucial as to identify the successful ablation site. Catheter ablation more than antiarrhythmic drug treatment is usually highly effective in eliminating idiopathic ventricular arrhythmias and providing prevention of recurrence. Conclusion Idiopathic VTs are not considered life-threatening arrhythmias and, prevention of recurrences is often achieved by means of catheter ablation that provides an improvement of quality of life. The overall acute success rate of catheter ablation is about 85-90% with a long–term prevention of arrhythmia recurrence of about 75-80%. It is advisable that the procedure is carried out by electrophysiologists with expertise in VT catheter ablation and extensive knowledge of cardiac anatomy as to ensure a high success rate and reduce the likelihood of major complications.
机译:简介在没有任何可检测的结构性心脏病的情况下,可能会发生室性心动过速或频繁的室性早搏(PVC)。在这种临床情况下,这些心律失常被称为特发性。通常,它们具有良好的预后,如果患者症状强烈,或更重要的是,如果频繁的室性心律失常可导致室功能障碍,则应进行任何可能的消融干预。方法综述了各种形式的特发性室性心动过速。右心室流出道室性心动过速是所谓的特发性室性心动过速的最常见形式。特发性室性心律失常的其他形式包括由三尖瓣环,二尖瓣环,束间室性心动过速和乳头肌室性心动过速引起的室性心动过速/ PVC。当认为需要介入治疗时,详细的定位(VT / PVC期间的最早激活,速度定位)对于确定成功的消融部位至关重要。导管消融比抗心律失常药物治疗通常在消除特发性室性心律不齐和预防复发方面非常有效。结论特发性室速不算危及生命的心律失常,通常通过导管消融术(可改善生活质量)来预防复发。导管消融的总体急性成功率约为85-90%,长期预防心律失常的复发率约为75-80%。建议该过程由具有VT导管消融专业知识和广泛的心脏解剖知识的电生理学家进行,以确保较高的成功率并减少重大并发症的可能性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号